SOURCE: Healthnostics, Inc.

December 22, 2010 09:41 ET

Healthnostics Addresses Stock Price

NEW YORK, NY--(Marketwire - December 22, 2010) - Healthnostics, Inc.'s (PINKSHEETS: HNSS) management addressed the issue of its 2010 earnings guidance of $.011 per share and its anticipated 2011 earnings justifying a more commensurate current market price. Management's analysis indicates that certain short-term factors have combined to interrupt normal market forces from properly pricing the stock. These factors include:

1. Transitioning of stockholder base in tandem with the Company's new direction and new management into medical manufacturing, consulting, distribution, and online distribution;
2. Year-end tax selling;
3. Short selling and management's refusal to deal with short sellers through sales of stock, etc.;
4. New management's opposition to paid stock promotions which tend to produce stock price peaks and valleys instead of stable increases.

Management strongly believes that its philosophy of concentrating on business fundamentals is the only long-term solution to improving and maintaining a representative stock price.

About Healthnostics

Healthnostics, Inc. is a medical products manufacturer, system manufacturer, product distribution, and consulting company. Healthnostics' subsidiary, Worldwide Wipes Co., is a major manufacturer and distributor of medical and general swabs.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information

  • Contact:
    Healthnostics, Inc.
    Investor Relations
    P. 301-956-3342
    Email Contact